Palvella Therapeutics (PVLA) Change in Cash (2016 - 2024)
Historic Change in Cash for Palvella Therapeutics (PVLA) over the last 12 years, with Q4 2024 value amounting to $69.4 million.
- Palvella Therapeutics' Change in Cash rose 244284.27% to $69.4 million in Q4 2024 from the same period last year, while for Dec 2024 it was $76.3 million, marking a year-over-year increase of 97615.76%. This contributed to the annual value of $76.3 million for FY2024, which is 97615.76% up from last year.
- According to the latest figures from Q4 2024, Palvella Therapeutics' Change in Cash is $69.4 million, which was up 244284.27% from -$330000.0 recorded in Q3 2024.
- Palvella Therapeutics' 5-year Change in Cash high stood at $69.4 million for Q4 2024, and its period low was -$34.0 million during Q1 2022.
- For the 5-year period, Palvella Therapeutics' Change in Cash averaged around $2.2 million, with its median value being -$2.0 million (2023).
- In the last 5 years, Palvella Therapeutics' Change in Cash plummeted by 84493.2% in 2022 and then soared by 244284.27% in 2024.
- Over the past 5 years, Palvella Therapeutics' Change in Cash (Quarter) stood at $3.5 million in 2020, then tumbled by 305.53% to -$7.3 million in 2021, then tumbled by 34.3% to -$9.8 million in 2022, then surged by 69.74% to -$3.0 million in 2023, then soared by 2442.84% to $69.4 million in 2024.
- Its Change in Cash stands at $69.4 million for Q4 2024, versus -$330000.0 for Q3 2024 and $8.3 million for Q2 2024.